Qinhua Jin Selected Research

Qinhua Jin Research Topics

2	Ischemia 03/2024 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2024
2	Thrombosis (Thrombus) 05/2021 - 06/2018
2	Reperfusion Injury 08/2017 - 03/2017
2	Hyperplasia 01/2014 - 04/2013
1	Myocardial Infarction 03/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024
1	Acute Coronary Syndrome 01/2024
1	Non-ST Elevated Myocardial Infarction 01/2024
1	Heart Failure 01/2024
1	Hyperemia 01/2022
1	Hemorrhage 05/2021
1	ST Elevation Myocardial Infarction 05/2021
1	Chest Pain (Chest Pains) 05/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2021
1	Pathologic Constriction (Stenosis) 03/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2020
1	Diabetes Mellitus 01/2014

2	omega-Chloroacetophenone (Mace)IBA 03/2024 - 01/2024
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2024
1	pro-brain natriuretic peptide (1-76)IBA 01/2024
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024
1	ElementsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Nicorandil (SG 75)IBA 01/2022
1	LipidsIBA 03/2021
1	Cytidine Triphosphate (CTP)IBA 01/2020
1	MelatoninIBA 08/2017
1	HexokinaseIBA 03/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017
1	Mitochondrial Permeability Transition PoreIBA 03/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2017
1	Voltage-Dependent Anion Channel 1IBA 03/2017
1	Cardiolipins (Cardiolipin)IBA 03/2017
1	PolymersIBA 04/2013

5	Percutaneous Coronary Intervention 03/2024 - 03/2017
3	Stents 06/2018 - 04/2013
2	Drug-Eluting Stents 01/2014 - 04/2013
1	Aftercare (After-Treatment) 01/2024
1	Catheters 05/2021
1	Thrombolytic Therapy 05/2021